CD19 Gene Immunodeficiency Common Variable Type 3 NGS Genetic DNA Test
Comprehensive Genetic Testing for Immune System Disorders
The CD19 Gene Immunodeficiency Common Variable Type 3 NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for immune system disorders. This advanced test specifically targets mutations in the CD19 gene, which plays a critical role in B-cell development and function. Common Variable Immunodeficiency Type 3 is a rare but serious condition that affects the body’s ability to produce effective antibodies, leading to increased susceptibility to infections and autoimmune complications.
What This Test Measures and Detects
Our state-of-the-art NGS Genetic DNA Test provides comprehensive analysis of the CD19 gene to identify:
- Point mutations and single nucleotide variants in the CD19 gene
- Insertions and deletions affecting gene function
- Copy number variations impacting B-cell development
- Genetic markers associated with Common Variable Immunodeficiency Type 3
- Inheritance patterns for family genetic counseling
Who Should Consider This Test
This genetic test is recommended for individuals experiencing:
- Recurrent bacterial infections, particularly respiratory infections
- Chronic sinusitis or bronchitis
- Autoimmune disorders affecting multiple systems
- Family history of immune deficiency disorders
- Unexplained inflammatory conditions
- Delayed diagnosis of immune system abnormalities
- Children with failure to thrive and recurrent infections
Clinical Benefits of CD19 Genetic Testing
Undergoing the CD19 Gene Immunodeficiency Common Variable Type 3 NGS Genetic DNA Test provides numerous clinical advantages:
- Early Diagnosis: Enables prompt identification of genetic immune disorders
- Personalized Treatment: Guides targeted therapeutic interventions
- Family Planning: Provides crucial information for genetic counseling
- Preventive Care: Helps implement proactive infection prevention strategies
- Improved Quality of Life: Reduces complications through early intervention
Understanding Your Test Results
Our comprehensive genetic analysis provides detailed insights into your immune system genetics:
- Positive Result: Indicates presence of CD19 gene mutations associated with Common Variable Immunodeficiency Type 3, requiring specialized immunology care
- Negative Result: Suggests absence of tested CD19 mutations, though other immune disorders may still be present
- Variant of Uncertain Significance: Identifies genetic changes requiring further clinical correlation
- Carrier Status: Determines inheritance patterns for family members
Test Pricing Information
| Test Component | Price (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We have comprehensive testing facilities across the United States, with specialized branches in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure consistent, high-quality genetic testing results nationwide.
Take Control of Your Immune Health Today
Don’t let unexplained immune symptoms compromise your quality of life. Our CD19 Gene Immunodeficiency Common Variable Type 3 NGS Genetic DNA Test provides the answers you need for proper diagnosis and treatment. With results available in 3-4 weeks and multiple sample collection options including blood, extracted DNA, or blood on FTA card, getting tested has never been more convenient.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic test and take the first step toward understanding your immune health.
